Researchers are excited about this new drug, a innovative dual compound showing significant outcomes in initial trials for body management. It functions by modulating two pathways : GLP-1 and GIP, which , when engaged , support regulate hunger and improve metabolism . Preliminary findings suggest substantial body management and potential advantages